COVID-19: Bharat Biotech's Covaxin likely to get WHO nod this week

The much-awaited nod by the World Health Organisation (WHO) for the Bharat Biotech's Covaxin is likely to be given this week, the ANI news agency reported on Monday (September 13, 2021). The development comes a month after Union Health Minister Mansukh Mandaviya met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the global health body's approval for the homegrown COVID-19 vaccine.

Bharat Biotech's Covaxin likely to get WHO nod

This is to be noted that all documents required for Emergency Use Listing (EUL) have been submitted by Bharat Biotech for Covaxin to WHO as of July 9 following which the review process by the global health body had commenced.

Developed by Bharat Biotech in partnership with the National Institute of Virology (NIV) and the Indian Council of Medical Research (ICMR), Covaxin was approved for emergency use in India on January 3.

Bharat Biotech in its Phase 3 trial results of Covaxin had claimed that it demonstrates overall vaccine efficacy of 77.8%. The Hyderabad-based company had said that the Covaxin has been proven 'safe' in India's largest efficacy trial and shared the final Phase-3 Pre-Print data published on medRxiv.

Meanwhile, the Office of Mansukh Mandaviya informed that India on Monday achieved the milestone of administering 75 crore COVID-19 vaccine doses.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.